Coordinate late expression of trefoil peptide genes (pS2/TFF1 and ITF/TFF3) in human breast, colon, and gastric tumor cells exposed to X-rays

Molecular Cancer Therapeutics

Volumn 1, Issue 6, 2002, Pages 405-415

  Balcer Kubiczek, Elizabeth K ^a   Harrison, George H ^a   Xu, Jing Fan ^a   Gutierrez, Peter L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; HYDROGEN PEROXIDE; MESSENGER RNA; MUCIN; MUSCLE PROTEIN; PEPTIDE; PHENOLSULFONPHTHALEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; RNA; TFF1 PROTEIN, HUMAN; TFF3 PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CLONOGENIC ASSAY; COLON TUMOR; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER; NORTHERN BLOTTING; OXIDATIVE STRESS; PATHOLOGY; RADIATION EXPOSURE; STOMACH TUMOR;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

APOPTOSIS; BLOTTING, NORTHERN; BREAST NEOPLASMS; CELL SURVIVAL; COLONIC NEOPLASMS; COLONY-FORMING UNITS ASSAY; ESTRADIOL; GENE EXPRESSION; HUMANS; HYDROGEN PEROXIDE; MUCINS; MUSCLE PROTEINS; NEOPLASM PROTEINS; OXIDATIVE STRESS; PEPTIDES; PHENOLSULFONPHTHALEIN; PROTEINS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0141497024     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Ribieras, S., Tomasetto, C., and Rio, M. C. The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochem. Biophys. Acta, 1378: F61-F77, 1998. (Pubitemid 28381126)
2. Masialkowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A., and Chambon, P. Cloning of cDNA sequences of hormone-regulated genes from the MCF7 human breast carcinoma cell line. Nucleic Acids Res., 10: 7895-7903, 1982.
3. Jorgensen, K. D., Diamenti, B., Jorgensen, K. H., and Thim, L. Pancreatic spasmolytic polypeptide (PSP): pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul. Peptides, 3: 231-243, 1982. (Pubitemid 12152695)
4. Suemori, S., Lynch-Devaney, K., and Podolsky, D. K. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc. Natl. Acad. Sci. USA, 88: 11017-11021, 1990.
5. Hanby, A. M., Poulsom, R., Singh, S., Elia, G., Jeffry, R. E., and Wright, N. A. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology, 105: 1110-1116, 1993. (Pubitemid 23281500)
6. Lefebvre, O., Wolf, C., Kedinger, M., Chenard, M. P., Tomasetto, C., Chambon, P., and Rio, M. C. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J. Cell Biol., 122: 191-198, 1993. (Pubitemid 23188810)
7. Podolsky, D. K., Lynch-Devaney, K., Snow, J. L., Oates, P., Murgue, B., DeBeaumont, M., Sands, B. E., and Mahida, Y. R. Identification of human intestinal trefoil factor. J. Biol. Chem., 268: 6694-6702, 1993.
8. Tomasetto, C., Rio, M. C., Gautier, C., Wolf, C., Hareuvani, M., Chambon, P., and Lathe, R. hSP, the domain duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach, but not in breast carcinoma. EMBO J., 9: 407-414, 1990.
9. Rio, M. C., Bellocq, J. P., Daniel, J. Y., Tomasetto, C., Lathe, R., Chenard, M. P., Balzenschlager, A., and Chambon, P. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science (Wash. DC), 241: 705-708, 1988.
10. Alison, M. R., Chinery, R., Poulsom, R., Ashwood, P., Longcoft, J. M., and Wright, N. A. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming factor α mRNAs in rat stomach. J. Pathol., 175: 405-414, 1995.
11. Mashimo, H., Wu, D. C., Podolsky, D. K., and Fishman, M. C. Impaired defence of intestinal mucosa in mice lacking intestinal trefoil factor. Science (Wash. DC), 274: 262-265, 1996. (Pubitemid 26353206)
12. Babyatsky, M. W., DeBeaumont, M., Thim, L., and Podolsky, D. K., Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology, 110: 489-497, 1996. (Pubitemid 26043882)
13. Wright, N. A., Poulsom, R., Stamp, G., Van-Noorden, S., Sarraf, C., Elia, G., Ahnen, D., Jeffery, R., Longcroft, J., Rio, M. C., and Chambon, P. Trefoil protein expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology, 104: 12-20, 1993. (Pubitemid 23040001)
14. Lefebvre, O., Chenard, M. P., Masson, R., Linares, J., Dierich, A., Le Meur, M., Wendling, C., Tomasetto, C., Chambron, P., and Rio, M. C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science (Wash. DC), 274: 259-262, 1996. (Pubitemid 26353205)
15. Playford, R. J., Marchbank, T., Chinery, R., Pignalli, M., Boulton, R. A., Thim, L., and Hanby, A. M. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology, 108: 108-116, 1995.
16. Chinery, R., and Playford, R. J. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin. Sci., 88: 401-403, 1995.
17. Playford, R. J., Marchbank, T., Goodlad, R. A., Chinery, R., Poulsom, R., and Hanby, A. M. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to interstitial damage. Proc. Natl. Acad. Sci. USA, 93: 2137-2142, 1996. (Pubitemid 26079894)
18. Tomasetto, C., Masson, R., Linares, J. L., Wendling, C., Lefebvre, O., Chenard, M. P., and Rio, M. C. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology, 118: 70-80, 2000. (Pubitemid 30020374)
19. Henry, J. A., Bennett, M. K., Piggott, N. H., Levett, D. L., May, F., and Westley, W. R. Expression of pNR2/pS2 protein in diverse epithelial tumors. Br. J. Cancer, 64: 677-681, 1991.
20. Poulsom, R., Hanby, A. M., Lalani, E. N., Hauser, F., Hoffmann, W., and Stamp, G. W. Intestinal trefoil factor (TFF3) and pS2 (TFF1), but not spasmolytic polypeptide (TFF2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J. Pathol., 183: 30-38, 1997. (Pubitemid 27368523)
21. Gillesby, B. E., and Zacharewski, T. R. pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers. Breast Cancer Res. Treat., 56: 253-265, 1999. (Pubitemid 29495656)
22. Ohshio, G., Suwa, H., Kawaguchi, Y., Imamura, M., Yamaoka, Y., Yamabe, H., Matsumoto, M., Yoshioka, H., Hashimoto, Y., and Takeda, H. Differential expression of human spasmolytic polypeptide (trefoil factor family-2) in pancreatic carcinomas, ampullary carcinomas, and mucin-producing tumors of the pancreas. Digest. Dis. Sci., 454: 659-664, 2000. (Pubitemid 30186044)
23. Uchino, H., Kataoka, H., Itoh, H., and Hamasuna, R. Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo. Gastroenterology, 118: 60-69, 2000. (Pubitemid 30020373)
24. Nogeira, A. M., Machado, J. C., Carneiro, F., Reis, C. A., Gott, P., and Sobrinho-Simoes, M. Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation. J. Pathol., 187: 541-548, 1999. (Pubitemid 29151995)
25. Welter, C., Theisinger, B., Seitz, G., Tomasetto, C., Chambon, M. C., and Blin, N. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinomas. Lab. Investig., 66: 187-192, 1992.
26. Welter, C., Theisinger, B., Rio, M. C., Seitz, G., Schruder, G., and Blin, N. Expression pattern of breast cancer associated protein pS2/BCEI in colorectal cancer. Int. J. Cancer, 56: 52-55, 1994. (Pubitemid 24044792)
27. Dos Santos Silva, E., Ulrich, M., Doring, G., Botzenhart, K., and Gott, P. Trefoil factor domain peptides in the human respiratory tract. J. Pathol., 190: 133-142, 2000. (Pubitemid 30082485)
28. Hanby, A. M., McKee, P., Jeffery, M., Grayson, W., Dublin, E., Poulsom, R., and Maguire, B. Primary mucinous carcinomas of skin express TFF1. TFF3, estrogen receptor, and progesterone receptors. Am. J. Surg. Pathol., 22: 1125-1131, 1998. (Pubitemid 28411071)
29. Biswas, D. K., Averboukh, L., Sheng, S., Martin, K., Ewaniuk, D. S., Jawde, T. F., Wang, F., and Pardee, A. B. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor. Mol. Med., 4: 454-467, 1998. (Pubitemid 28419090)
30. Thompson, A. M., Elton, R. A., Hawkins, R. A., Chetty, U., and Steel, C. M. PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer. Br. J. Cancer, 77: 492-496, 1998. (Pubitemid 28044057)
31. May, F. E., and Westley, B. R. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J. Pathol., 182: 404-412, 1997.
32. Brown, A. M. C., Jeltsch, J. M., Roberts, M., and Chambon, P. Activation of pS2 transcription in a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. USA, 81: 6344-6348, 1984. (Pubitemid 15220836)
33. Nunez, A. M., Jakowlev, S., Briand, J. P., Gaire, M., Krust, A., Rio, M. C., and Chambron, P. Characterization of the estrogen-induced pS2 protein secreted in the human breast cancer cell line MCF-7. Endocrinology, 121: 1759-1765, 1987. (Pubitemid 18012781)
34. Berry, M., Nunez, A. M., and Chambon, P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA, 86: 1218-1222, 1989. (Pubitemid 19062558)
35. Baldwin, W. S., Travlos, G. S., Risinger, J. I., and Barrett, J. C. Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells. Carcinogenesis (Lond.), 19: 1895-1908, 1998.
36. Martin, V., Ribieras, S., Sing-Wang, X. G., Lasne, Y., Frappart, L., Rio, M. C., and Dante, R. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers. J. Cell. Biochem., 65: 95-106, 1997. (Pubitemid 27188072)
37. Badia, E., Duschesne, M. J., Semlali, A., Fuentes, M., Giamarchi, C., Richards-Foy, H., Nicolas, J. C., and Pons, M. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. Cancer Res., 60: 4130-4138, 2000. (Pubitemid 30636595)
38. Williams, R., Elia, G., Stamp, G. W. H., Oates, T., Wright, N. A., and Lalani, E. N. Characterization of monoclonal antibodies raised to C-terminal peptides of pS2: a major trefoil peptide and motility factor expressed in adenocarcinomas and regions of mucosal injury. Hum. Pathol., 27: 1259-1266, 1996. (Pubitemid 26415316)
39. Miyashita, S., Nomoto, H., Konishi, H., and Hayashi, K. Estimation of pS2 protein level in human body fluids by a sensitive two-site enzyme immunoassay. Clin. Chim. Acta, A228: 71-81, 1994.
40. Wilson, Y. G., Rhodes, M., Ibrahim, N. B., Padfield, P. J., and Cawthorn, S. J. Immunocytochemical staining of pS2 protein in fine-needle aspirate from breast cancer is an accurate guide to response to tamoxifen in patients aged over 70 years. Br. J. Surg., 81: 1155-1158, 1994. (Pubitemid 24262941)
41. Nichols, P. H., Ibrahim, N. B., Padfield, C. J., and Cawthorn, S. J. Correlation of pS2 expression of involved lymph nodes in relation to primary breast carcinoma. Eur. J. Surg. Oncol., 21: 151-154, 1995.
42. Harding, C., Osundeko, O., Tetlow, L., Faragher, E. B., Howell, A., and Bundred, N. J. Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity. Br. J. Cancer, 82: 354-360, 2000. (Pubitemid 30045381)
43. Sonnenschein, C., Soto, A. M., Fernandez, M. F., Olea, N., Olea-Serrano, M. F., and Ruiz-Lopez, M. D. Development of a marker of estrogenic exposure in human serum. Clin. Chem., 41: 1888-1895, 1994.
44. Romagnolo, D., Annab, L. S., Thompson, T. E., Risinger, J. L., Terry, L. A., Barrett, J. C., and Afshari, C. A. Estrogen upregulation of BRCA1 expression with no effect on localization. Mol. Carcinog., 22: 102-109, 1998. (Pubitemid 28298427)
45. Rosenberg Zand, R. S., Grass, L., Magklara, A., Jenkins, D. J., and Diamandis, E. P. Is ICI 182,780 an antiprogestin in addition to being an antiestrogen? Breast Cancer Res. Treat., 60: 1-8, 2000. (Pubitemid 30307459)
46. Jain, P. T., Rajah, T. T., and Pento, J. T. Antitumor activity of a novel antiestrogen (analog II) on human breast carcinoma cells. Anticancer Drugs, 8: 964-973, 1997. (Pubitemid 28027095)
47. Bonefeld Jorgensen, E. C., Antrup, H., and Hansen, J. C. Effect of toxaphene on estrogen receptor function in human breast cancer cells. Carcinogenesis (Lond.), 18: 1651-1654, 1997. (Pubitemid 28134792)
48. Stoica, A., Pentecost, E., and Martin, M. B. Effects of arsenite on estrogen receptor-α expression and activity in MCF-7 breast cancer cells. Endocrinology, 141: 3595-3602, 2000.
49. Stoica, A., Pentecost, E., and Martin, M. B. Effects of selenite on estrogen receptor-α expression and activity in MCF-7 breast cancer cells. J. Cell Biochem., 79: 282-292, 2000.
50. Riby, J. E., Chang, G. H., Firestone, G. L., and Bjeldanes, L. F. Ligand-independent activation of estrogen receptor function by 3, 3′-diindolylmethane in human breast cancer cells. Biochem. Pharmacol., 60: 167-177, 2000. (Pubitemid 30312944)
51. Ren, L., Marquardt, M. A., and Lech, J. J. Estrogenic effects of nonphenol on pS2. ER and MUC1 gene expression in human breast cancer cells - MCF7. Chem. Biol. Interact., 104: 55-64, 1997. (Pubitemid 27199533)
52. Duda, R. B., Zhong, Y., Navas, V., Li, M. Z., Toy, B. R., and Alavarez, J. G. American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J. Surg. Oncol., 72: 230-239, 1999. (Pubitemid 30007793)
53. Jorgensen, M., Vendelbo, B., Skakkerbak, N. E., and Leffers, H. Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. Environ. Health Perspect., 108: 403-412, 2000. (Pubitemid 30421017)
54. Balcer-Kubiczek, E. K., Zhang, X. F., Harrison, G. H., Zhou, X. J., Vigneulle, R. M., Ove, R., McCready, W. A., and Xu, J. F. Delayed expression of hpS2 and prolonged expression of CIP1/WAF1/SDI1 in human tumour cells irradiated with X-rays, fission neutrons or 1 GeV/nucleon Fe ions. Int. J. Radiat. Biol., 75: 529-541, 1999. (Pubitemid 29243131)
55. Seib, T., Blin, N., Seifert, M., Theisinger, B., Engel, M., Dooley, S., Zang, K. D., and Welter, C. The three human genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3. Genomics, 40: 200-202, 1997. (Pubitemid 27108274)
56. Clutton, S. M., Townsend, K. M. S., Walker, C., Ansell, J. D., and Wright, E. G. Radiation-induced genomic instability in primary bone marrow cultures. Carcinogenesis (Lond.), 17: 1633-1639, 1996. (Pubitemid 26280385)
57. Balcer-Kubiczek, E. K., Yin, J., Lin, K., Harrison, G. H., Abraham, J. M., and Meltzer, S. J. p53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X rays or fission neutrons. Radiat. Res., 142: 256-262, 1995.
58. Gu, Y., Desai, T., Gutierrez, P. L., and Lu, A-L. Alteration of DNA base excision repair enzymes hMYH and hOGG1 in hydrogen peroxide resistant transformed human breast cells. Med. Sci. Monit., 7: 861-868, 2001. (Pubitemid 32928601)
59. Kennedy, A. S., Harrison, G. H., Mansfield, C. M., Zhou, X. J., Xu, J. F., and Balcer-Kubiczek, E. K. Survival of colorectal cancer cell lines treated with paclitaxel, radiation, and 5-FU: effect of TP53 or hMLH1 deficiency. Int. J. Cancer (Radiat. Oncol. Investig.), 90: 175-185, 2000.
60. Lengauer, C., Kinzler, K. W., and Vogelstein, B. Genetic instability in colorectal cancers. Nature (Lond.), 86: 623-627, 1997. (Pubitemid 27175430)
61. Bunz, F., Dutriaux, A., Langauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (Wash. DC), 282: 1497-1501, 1998. (Pubitemid 28538613)
62. Fairchild, C. R., Ivy, S. P., Kao-Shan, C. S., Whang-Peng, J., Rosen, N., Isreal, M. A., Melera, P. W., Cowen, K. W., and Goldsmith, M. E. Isolation of overamplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res., 47: 5141-5148, 1987. (Pubitemid 17146486)
63. Kyprianou, N., English, H. F., Davidson, N. E., and Isaacs, J. T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51: 162-166, 1991.
64. Perillo, B., Sasso, A., Abbondanza, C., and Palumbo, G. 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell. Biol., 20: 2890-2901, 2000. (Pubitemid 30183508)
65. Lane, L. A., Romagnoli, L., Cruise, B., and Cohn, G. M. Spontaneous conversion to estrogen receptor expression by the human breast epithelial cell line, MCF-10A. Oncol. Rep., 6: 507-511, 1999.
66. Shomori, K., Sakatani, T., Goto, A., Matsuura, T., Kiyonari, H., and Ito, H. Thymidine phosphorylase expression in human colorectal mucosa, adenoma and carcinoma: role of p53 expression. Pathol. Int., 49: 491-499, 1999. (Pubitemid 29411163)
67. Thottassery, J. V., Zambetti, G. P., Arimori, K., Schuetz, E. G., and Schuetz, J. D. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc. Natl. Acad. Sci. USA, 94: 11037-11042, 1997. (Pubitemid 27430856)
68. Balcer-Kubiczek, E. K., Zhang, X. F., Harrison, G. H., McCready, W. A., Shi, Z. M., Abraham, J. M., Ampey, L. L., III, Meltzer, S. J., Jacobs, M. C., and Davis, C. C. Rodent cell transformation and immediate early gene expression following 60-Hz magnetic field exposure. Environ. Health Perspect., 204: 1188-1198, 1996. (Pubitemid 27028851)
69. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6-13, 1983.
70. Limoli, C. L., Ponnaiya, B., Corcoran, J. J., Giedzinski, E., Kaplan, M. I., Hartmann, A., and Morgan, W. F. Genomic instability induced by high and low LET ionizing radiation. Adv. Space Res., 25: 2107-2117, 2000.
71. Mothersill, C., and Seymour, C. Radiation-induced bystander effects: past history and future directions. Radiat. Res., 155: 759-767, 2001. (Pubitemid 32494601)
72. Iyer, R., and Lehnert, B. E. Effects of ionizing radiation in targeted and nontargeted cells. Arch. Biochem. Biophys., 376: 14-25, 2000. (Pubitemid 30205110)
73. Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., and Vogelstein, B. Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. USA, 96: 14517-14522, 1999. (Pubitemid 30000682)
74. Amundson, S. A., Bitter, M., Chen, Y., Trent, J., Meltzer, P., and Fornace, A. J., Jr. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene, 18: 3666-3672, 1999. (Pubitemid 29322393)
75. Balcer-Kubiczek, E. K., Meltzer, S. J., Han, L-H., Zhang, X-F., Shi, Z-M., Harrison, G. H., and Abraham, J. M. Csa-19, a radiation-responsive human gene, identified by an unbiased two-gel cDNA library screening method in human cancer cells. Oncogene, 14: 3051-3058, 1997.
76. Narayanan, P. K., LaRue, K. E., Goodwin, E. H., and Lehnert, B. E. Alpha particles induce the production of interleukin-8 by human cells. Radiat. Res., 152: 57-63, 1999. (Pubitemid 29296246)
77. Chang, P. Y., Bjornstad, K. A., Chang, E., McNamara, M., Barcellos-Hoff, M. H., Lin, S. P., Aragon, G., Polansky, J. R., Lui, G. M., and Blakely, E. A. Particle irradiation induced FGF2 expression in normal human lens cells. Radiat. Res., 154: 477-484, 2000.
78. Zhang, W., Spitz, D. R., Oberley, L. W., and Robbins, M. E. C. Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibi-tor- 1 following ionizing radiation. Cancer Res., 61: 5537-5543, 2001. (Pubitemid 32694939)
79. Dahm-Daphi J., Sass, C., and Alberti, W. Comparison of biological effects of DNA damage induced by ionizing radiation and hydrogen peroxide in CHO cells. Int. J. Radiat. Biol., 76: 67-75, 2000. (Pubitemid 30048028)
80. Parchment, R. E., Lewellyn, A., Swartzendruber, D., and Pierce, G. B. Serum amine oxidase contributes to crisis in mouse embryo cell lines. Proc. Natl. Acad. Sci. USA, 97: 4340-4344, 1990.
81. Mendrysa, S. M., and Perry, M. E. The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under condition of stress. Mol. Cell. Biol., 20: 2023-2030, 2000. (Pubitemid 30123818)
82. Ramirez, R. D., Morales, C. P., Herbert, B. S., Rohde, J. M., Passons, C., Shay, J. W., and Wright, W. E. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev., 15: 398-403, 2001. (Pubitemid 32187001)
83. Akman, S. A., Forrest, G., Chu, F. F., and Doroshow, J. H. Resistance to hydrogen peroxide associated with altered catalase mRNA stability in MCF7 breast cancer cells. Biochim. Biophys. Acta, 1009: 70-74, 1989. (Pubitemid 19218396)
84. Taupin, D. R., Kinoshita, K., and Podolsky, D. K. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc. Natl. Acad. Sci. USA, 97: 799-804, 2000. (Pubitemid 30070390)
85. Beck, S., Sommer, P., Dos Santos Silva, E., Blin, N., and Gott, P. Hepatocyte nuclear factor 3 (winged helix domain) activates trefoil factor gene TFF1 through a binding motif adjacent to the TATAA box. DNA Cell Biol., 18: 157-164, 1999. (Pubitemid 29095995)
86. Efstathiou, J. A., Noda, M., Rowan, A., Dixon, C., Chinery, R., Jawhari, A., Hattori, T., Wright, N. A., Bodmer, W. F., and Pignatelli, M. Intestinal trefoil factor controls the expression of the adenomatous polyposis colicatenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc. Natl. Acad. Sci, USA, 95: 3122-3127, 1998. (Pubitemid 28135865)
87. Ron, E. Ionizing radiation and cancer risk. Radiat. Res., 150: S30-S41, 1998.